Compound 2280
Identifiers
- Canonical SMILES:
CCC(C(C)OC)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1
- IUPAC name:
2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(2-methoxypentan-3-yl)-3-methyl-2-oxopiperidin-3-yl]acetic acid
- InChi:
InChI=1S/C26H31Cl2NO4/c1-5-22(16(2)33-4)29-24(17-9-11-19(27)12-10-17)21(18-7-6-8-20(28)13-18)14-26(3,25(29)32)15-23(30)31/h6-13,16,21-22,24H,5,14-15H2,1-4H3,(H,30,31)/t16?,21-,22?,24-,26-/m1/s1
- InChiKey:
RJULIFZYUVRMFB-MRZXJGQFSA-N
External links
![]() 156471534 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.70 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 491.16 g/mol | |||
HBA | 5 | |||
HBD | 1 | |||
HBA + HBD | 6 | |||
AlogP | 6.11 | |||
TPSA | 69.67 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 1 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/ml500142b | 2 | MDM2 Q00987 |
P53 P04637 |
Biochemical assay | HTRF | pIC50 (half maximal inhibitory concentration, -log10) | 8.70 | |
10.1021/ml500142b | 2 | MDM2 Q00987 |
P53 P04637 |
Cellular assay | EdU Cell Proliferation Assay | SJSA-1 cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.84 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7172 | AMG-232 | DB15299 | |
0.6308 | Osanetant | DB04872 | |
0.6212 | Skf 107457 | DB04191 | |
0.5985 | (2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide | DB02704 | |
0.5902 | Dexetimide | DB08997 | |
0.5802 | Saredutant | DB06660 | |
0.5704 | methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate | DB08505 | |
0.5610 | Sacubitrilat | DB14127 | |
0.5574 | Nateglinide | DB00731 | |
0.5547 | Sacubitril | DB09292 | |
0.5496 | Aspartame | DB00168 | |
0.5442 | RB106 | DB02669 | |
0.5419 | Quinapril | DB00881 | |
0.5391 | (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL | DB07909 | |
0.5378 | 6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid | DB03471 |